Lund University is celebrating 350 years.


Javascript is not activated in your browser. This website needs javascript activated to work properly.

Novel microRNA regulators of atrial natriuretic peptide production

  • Connie Wu
  • Pankaj Arora
  • Obiajulu Agha
  • Liam A. Hurst
  • Kaitlin Allen
  • Daniel I. Nathan
  • Dongjian Hu
  • Pawina Jiramongkolchai
  • Gustav Smith
  • Olle Melander
  • Sander Trenson
  • Stefan P. Janssens
  • Ibrahim Domian
  • Thomas J Wang
  • Kenneth D. Bloch
  • Emmanuel S. Buys
  • Donald B. Bloch
  • Christopher Newton-Cheh
Publishing year: 2016
Language: English
Pages: 1977-1987
Publication/Series: Molecular and Cellular Biology
Volume: 36
Issue: 14
Document type: Journal article
Publisher: American Society for Microbiology

Abstract english

Atrial natriuretic peptide (ANP) has a central role in regulating blood pressure in humans. Recently, microRNA 425 (miR-425) was found to regulate ANP production by binding to the mRNA of NPPA, the gene encoding ANP. mRNAs typically contain multiple predicted microRNA (miRNA)-binding sites, and binding of different miRNAs may independently or coordinately regulate the expression of any given mRNA. We used a multifaceted screening strategy that integrates bioinformatics, next-generation sequencing data, human genetic association data, and cellular models to identify additional functional NPPA-targeting miRNAs. Two novel miRNAs, miR-155 and miR-105, were found to modulate ANP production in human cardiomyocytes and target genetic variants whose minor alleles are associated with higher human plasma ANP levels. Both miR-155 and miR-105 repressed NPPA mRNA in an allele-specific manner, with the minor allele of each respective variant conferring resistance to the miRNA either by disruption of miRNA base pairing or by creation of wobble base pairing. Moreover, miR-155 enhanced the repressive effects of miR-425 on ANP production in human cardiomyocytes. Our study combines computational, genomic, and cellular tools to identify novel miRNA regulators of ANP production that could be targeted to raise ANP levels, which may have applications for the treatment of hypertension or heart failure.


  • Cell and Molecular Biology
  • Cardiac and Cardiovascular Systems


  • Molecular Epidemiology and Cardiology
  • Hypertension and Cardiovascular Disease
  • ISSN: 0270-7306
E-mail: gustav [dot] smith [at] med [dot] lu [dot] se

Associate professor


+46 46 17 26 33



Research project participant

Cardiovascular Epigenetics


Research project participant

Heart Failure and Mechanical Support


Project manager

Molecular Epidemiology and Cardiology

+46 46 17 26 33


Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00